Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07819435
PHASE2/PHASE3

Phase 2/3 Efficacy and Safety of PP405 in Adult Males

Sponsor: Pelage Pharmaceuticals, Inc.

View on ClinicalTrials.gov

Summary

The study is designed to validate efficacy and long term safety of PP405.

Official title: A Randomized, Multicenter, Double-blind, Vehicle-controlled, Phase 2/3 Study to Assess Efficacy and Long-Term Safety of PP405 in Adult Males With Androgenetic Alopecia

Key Details

Gender

MALE

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

600

Start Date

2026-09

Completion Date

2028-06

Last Updated

2026-09-18

Healthy Volunteers

No

Interventions

DRUG

PP405 0.05% Topical Gel

Medicated topical gel containing PP405 0.05%

DRUG

Vehicle Topical Gel

Topical gel